New Drug Delivery System Targets Diseases at a Genetic Level

News   Dec 06, 2017 | Original story from University of Connecticut

 
New Drug Delivery System Targets Diseases at a Genetic Level

Enzyme-triggered degradation of a drug loaded peptide-crosslinked nucleic acid nanocapsule. First a peptide is crosslinked at the nanoparticle surface (1), then an enzyme recognizes the peptide crosslinker (2), and finally the enzyme cleavage leads to the release of the drug and any intact DNA (3). Credit: (Artwork by Joseph Luciani/UConn)

 
 
 

RELATED ARTICLES

An Artificial Mole As An Early Warning Sign

News

ETH researchers have developed an early warning system for the four most common types of cancer. Should a tumour develop, a visible mole will appear on the skin.

READ MORE

A New Listeria Species From Costa Rica

News

Listeria costaricensis is the official name given to the new bacterial species, discovered in an industrial drainage area in the Costa Rican province of Alajuela.

READ MORE

New Microscope Captures Detailed 3-D Movies of Cells Deep Within Living Systems

News

Merging lattice light sheet microscopy with adaptive optics reveals the most detailed picture yet of subcellular dynamics in multicellular organisms.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Cell Science Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE